Dabigatran's 'real-world' data about risk of myocardial infarction and gastrointestinal bleeding contradicts with randomized trials
- PMID: 23810890
- DOI: 10.1016/j.jacc.2013.05.066
Dabigatran's 'real-world' data about risk of myocardial infarction and gastrointestinal bleeding contradicts with randomized trials
Comment in
-
Reply: Dabigatran's 'real-world' data about risk of myocardial infarction and gastrointestinal bleeding contradicts with randomized trials.J Am Coll Cardiol. 2013 Sep 3;62(10):946-7. doi: 10.1016/j.jacc.2013.05.067. Epub 2013 Jun 27. J Am Coll Cardiol. 2013. PMID: 23810887 No abstract available.
Comment on
-
Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study.J Am Coll Cardiol. 2013 Jun 4;61(22):2264-73. doi: 10.1016/j.jacc.2013.03.020. Epub 2013 Apr 3. J Am Coll Cardiol. 2013. PMID: 23562920
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical